Adamo, Vincenzo
 Distribuzione geografica
Continente #
EU - Europa 92
NA - Nord America 52
AS - Asia 18
Totale 162
Nazione #
US - Stati Uniti d'America 51
IE - Irlanda 47
SE - Svezia 22
HK - Hong Kong 10
IT - Italia 8
DE - Germania 7
FI - Finlandia 6
SG - Singapore 5
IR - Iran 3
UA - Ucraina 2
CA - Canada 1
Totale 162
Città #
Dublin 47
Hong Kong 10
West Jordan 10
Helsinki 6
Andover 5
Bremen 4
Lawrence 4
Princeton 4
Wilmington 4
Ashburn 3
Magnago 2
Singapore 2
Ardabil 1
Biella 1
Jacksonville 1
Leawood 1
San Mateo 1
Toronto 1
Woodbridge 1
Zanjan 1
Totale 109
Nome #
Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy 43
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort 40
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study 35
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy 33
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status 16
Totale 167
Categoria #
all - tutte 1.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 3 2 0
2021/202234 6 0 1 4 6 0 4 1 0 4 4 4
2022/202360 12 2 4 0 4 4 3 0 31 0 0 0
2023/202459 2 2 9 2 8 7 10 1 0 11 2 5
2024/20259 0 1 8 0 0 0 0 0 0 0 0 0
Totale 167